Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH.

Pediatrics. 2008 Feb;121(2):317-25. doi: 10.1542/peds.2007-1583.

2.

Left ventricular diastolic dysfunction in bronchopulmonary dysplasia.

Mourani PM, Ivy DD, Rosenberg AA, Fagan TE, Abman SH.

J Pediatr. 2008 Feb;152(2):291-3. doi: 10.1016/j.jpeds.2007.11.006.

3.

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH.

J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031.

4.

Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.

Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP.

Pediatrics. 2007 Dec;120(6):1260-9.

PMID:
18055675
5.

Sildenafil for pulmonary hypertension in neonates.

Shah PS, Ohlsson A.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005494. Review. Update in: Cochrane Database Syst Rev. 2011;(8):CD005494.

PMID:
17636802
6.

Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn.

Abman SH.

Neonatology. 2007;91(4):283-90. Epub 2007 Jun 7. Review.

PMID:
17575471
7.

Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.

Noori S, Friedlich P, Wong P, Garingo A, Seri I.

Neonatology. 2007;91(2):92-100. Epub 2006 Nov 20.

PMID:
17344658
8.

The nitric oxide/cGMP signaling pathway in pulmonary hypertension.

Klinger JR.

Clin Chest Med. 2007 Mar;28(1):143-67, ix. Review.

PMID:
17338933
9.

Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.

Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS.

Am J Respir Crit Care Med. 2006 Nov 1;174(9):1042-7. Epub 2006 Aug 17.

PMID:
16917115
10.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1.

11.

Effects of long-term bosentan in children with pulmonary arterial hypertension.

Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ.

J Am Coll Cardiol. 2005 Aug 16;46(4):697-704.

12.
13.

Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus.

Deruelle P, Grover TR, Storme L, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L727-33. Epub 2004 Dec 17.

14.

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia.

Mourani PM, Ivy DD, Gao D, Abman SH.

Am J Respir Crit Care Med. 2004 Nov 1;170(9):1006-13. Epub 2004 Jun 7.

PMID:
15184202
15.
16.

Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.

Mikhail GW, Prasad SK, Li W, Rogers P, Chester AH, Bayne S, Stephens D, Khan M, Gibbs JS, Evans TW, Mitchell A, Yacoub MH, Gatzoulis MA.

Eur Heart J. 2004 Mar;25(5):431-6.

PMID:
15033256
17.

Inhaled iloprost: in primary pulmonary hypertension.

Goldsmith DR, Wagstaff AJ.

Drugs. 2004;64(7):763-73; discussion 774-5.

PMID:
15025551
18.

The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.

Dillon PW, Cilley RE, Mauger D, Zachary C, Meier A.

J Pediatr Surg. 2004 Mar;39(3):307-12; discussion 307-12.

PMID:
15017543
19.

Sitaxsentan therapy for pulmonary arterial hypertension.

Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, McLaughlin V, Hill N, Tapson VF, Robbins IM, Zwicke D, Duncan B, Dixon RA, Frumkin LR; STRIDE-1 Study Group.

Am J Respir Crit Care Med. 2004 Feb 15;169(4):441-7. Epub 2003 Nov 20.

PMID:
14630619
20.

Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.

Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.

Circulation. 2003 Oct 28;108(17):2066-9. Epub 2003 Oct 20.

Supplemental Content

Support Center